Rheumatoid Arthritis Completed Phase 2 Trials for Tabalumab (DB11657)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00308282A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participants With Rheumatoid ArthritisTreatment
NCT00689728A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor TherapyTreatment
NCT00837811An Open Label Extension Study in Participants With Rheumatoid ArthritisTreatment
NCT00785928A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate TherapyTreatment